Pharmaceutical Lobbying

GLP-1 Weight-Loss Push Intensifies as Novo Leads Ads and Wegovy Pill Drives Telehealth Uptake

New disclosures show continued lobbying on pricing, Medicare coverage, and access despite public deals with the Trump administration.